WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2011012322) SYNTHESIS AND USE OF VILDAGLIPTIN FOR THE PREPARATION OF PHARMACEUTICAL DOSAGE FORMS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2011/012322    International Application No.:    PCT/EP2010/004689
Publication Date: 03.02.2011 International Filing Date: 30.07.2010
IPC:
C07D 207/16 (2006.01), A61K 31/4015 (2006.01), A61K 9/16 (2006.01)
Applicants: KRKA, d.d., Novo mesto [SI/SI]; Smarjeska cesta 6 8501 Novo Mesto (SI) (For All Designated States Except US).
ZUPET, Rok [SI/SI]; (SI) (For US Only).
SMODIS, Janez [SI/SI]; (SI) (For US Only).
STROPNIK, Tadej [SI/SI]; (SI) (For US Only).
ANDERLUH, Marko [SI/SI]; (SI) (For US Only).
VRBINC, Miha [SI/SI]; (SI) (For US Only).
VRECER, Franc [SI/SI]; (SI) (For US Only).
PECAVAR, Anica [SI/SI]; (SI) (For US Only).
KUKEC, Simon [SI/SI]; (SI) (For US Only)
Inventors: ZUPET, Rok; (SI).
SMODIS, Janez; (SI).
STROPNIK, Tadej; (SI).
ANDERLUH, Marko; (SI).
VRBINC, Miha; (SI).
VRECER, Franc; (SI).
PECAVAR, Anica; (SI).
KUKEC, Simon; (SI)
Agent: WESTENDORP, Michael; Westendorp, Sommer Uhlandstr. 2 80336 München (DE)
Priority Data:
P-200900216 31.07.2009 SI
P-200900295 16.10.2009 SI
Title (EN) SYNTHESIS AND USE OF VILDAGLIPTIN FOR THE PREPARATION OF PHARMACEUTICAL DOSAGE FORMS
(FR) SYNTHÈSE ET UTILISATION DE VILDAGLIPTINE POUR PRÉPARER DES FORMES GALÉNIQUES PHARMACEUTIQUES
Abstract: front page image
(EN)The present invention relates the synthesis of vildagliptin in the presence of phase transfer catalysts; as well as the use of vildagliptin or its pharmaceutically acceptable salts for the preparation of solid oral dosage forms.
(FR)L'invention concerne la synthèse de vildagliptine en présence de catalyseurs de transfert de phase; ainsi que l'utilisation de vildagliptine ou de ses sels pharmaceutiquement acceptables pour préparer des formes galéniques orales solides.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)